CochlearMEX:COHN 75 OCF Margin % is 11.72% as of Dec. 2025, which is 36% below its 10-year median of 18.42. GuruFocus rates MEX:COHN with a GF Score™ of 75/100 and a GF Value™ of MXN6,298.88. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Cochlear ranks better than 60.61% on this metric.
The historical rank and industry rank for Cochlear's OCF Margin % or its related term are showing as below:
MEX:COHN'
s OCF Margin % Range Over the Past 10 Years
Min: -11.95 Med: 18.42 Max: 22.84
Current: 11.3
During the past 13 years, the highest OCF Margin % of Cochlear was 22.84%. The lowest was -11.95%. And the median was 18.42%.
MEX:COHN's OCF Margin % is ranked better than 60.61% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs MEX:COHN: 11.30
Cochlear OCF Margin % Related Terms
Cochlear OCF Margin % Historical Data
* Premium members only.
The historical data trend for Cochlear's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:COHN vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Cochlear's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cochlear OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Cochlear's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cochlear (MEX:COHN) has a OCF Margin % of 11.72% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cochlear and its competitors. This is 36% below median its historical median of 18.42. According to the industry distribution chart, Cochlear ranks #321 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 39.4%.
Is Cochlear's OCF Margin % too high?
Cochlear's current OCF Margin % of 11.72% is 36% below median its 10-year median of 18.42. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Cochlear's value of 11.72% is 100% above this industry median. Based on the distribution chart, Cochlear ranks #321 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Cochlear has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Cochlear's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cochlear ranks #321 out of 815 companies for OCF Margin %. This puts Cochlear in the upper half of its industry. The industry median OCF Margin % is 5.86. Cochlear's value of 11.72% is 100% above this benchmark. While the company's 10-year median is 18.42 vs. the industry median of 5.86, Cochlear has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cochlear's current OCF Margin % of 11.72% is 100% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cochlear and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cochlear's current OCF Margin % is 11.72%, which is 36% below median its own 10-year median of 18.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Cochlear (MEX:COHN) has a current OCF Margin % of 11.72%. The stock's GF Value™ is MXN6,298.88, compared to a current price of MXN2,391.38 — trading 62% below its estimated fair value. The current OCF Margin % is 11.72%, which is 36% below median its 10-year median of 18.42 and 100% above the Medical Devices & Instruments industry median of 5.86. Cochlear's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cochlear (MEX:COHN), the current OCF Margin % is 11.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cochlear (MEX:COHN) Overvalued in 2026?
Based on GuruFocus' analysis, Cochlear stock appears to be undervalued.
The current stock price of MXN2,391.38 is trading 62% below its estimated GF Value™ of MXN6,298.88.
Key valuation signals for MEX:COHN:
OCF Margin %: 11.72% (36% below median its 10-year median of 18.42)
GF Value™: MXN6,298.88 vs. price of MXN2,391.38 (62% below fair value)
Industry Position: 100% above the Medical Devices & Instruments median (#321 of 815)
No single metric tells the full story. See the MEX:COHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
75GF Score
Get the complete analysis for MEX:COHN
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:COHN has been successfully added to your 
